Interleukin 6 (IL-6) is a proinflammatory cytokine implicated in the pathogenesis of atherosclerosis.97 IL-6 signaling promotes hepatic synthesis of acute-phase reactants like C-reactive protein (CRP) and fibrinogen, which can serve as biomarkers of this pathway. This evidence concerns the gene IL6 and atherosclerosis.